Science, in human terms
Metabolites
tell your biological story.
Metabolomics explores part of biological activity, complementing the other omics.
Open the presentationThe science of a more personal future
Understand the person.
Reimagine the possibilities.
Our ambition is a human virtual twin for every person: a biological reference that evolves over time and helps bring personalized, precise and proactive health within reach.
The BioTwin method
From your biology
to your virtual twin.
How the twin takes shape
BioTwin brings advanced biomarker reading and proprietary statistical modeling together. The result is a connected representation of your biology, designed to gain context with every new observation.
Explore the full presentation
Collect biological information
At-home biomarker testing, explainedCollection and personal context
At-home sampling and personal context provide the starting point. Repeat collections create a history of your biology.
Read the signals
Understanding metabolomicsMetabolomics, explained
High-resolution mass spectrometry captures hundreds of biomarkers linked to biological activity; our statistical algorithms read them together as Bio-Signatures.
Build Bio-Signatures
Understanding Bio-SignaturesBio-Signatures, explained
Advanced analytics connect related signals into proprietary Bio-Signatures, making complex biological patterns easier to explore.
Reconstruct and update
Understanding the Human Virtual TwinYour reference over time
BioTwin's virtual model brings those patterns together with your context. New observations update your personal reference and reveal the story across time.
The wider research landscape
New questions.
More possibilities.
Beyond the first medical roadmap, BioTwin's research explores connections across oncology, neurology, cardiovascular function, women's health, fatigue and metabolism.
Oncology
A more personal approach to early detection.
Research focus
Breast · Colorectal · Lung · Pancreatic · Prostate · Ovarian
Cancer Bio-Signatures lead the medical roadmap, with breast and colorectal applications at the forefront of the UAE clinical pathway.
Explore oncologyNeurology
New insight into complex neurological conditions.
Research focus
Parkinson's · Dementia · Depression · Epilepsy
Research explores whether metabolic patterns can add useful biological context to conditions that are often difficult to characterize.
Explore neurologyCardiology
Understand the biology behind cardiovascular change.
Research focus
Heart failure · Hypertension
Cardiovascular research extends the platform toward a more personal view of risk, physiological change and clinical follow-up.
Explore cardiologyMetabolic health & beyond
Connect the systems that shape everyday health.
Research focus
Pre-diabetes & obesity · Women's health · Allergy, immunity & sensitivity · ME/CFS
These programs explore the links between metabolism, symptoms, lifestyle and longer-term health.
Explore the researchThese are research and development areas. Medical access is currently through participating physicians in the United Arab Emirates.
The horizon
Medicine that knows
your story.
The long-term vision
Our vision reaches from recognizing meaningful biological change to supporting more personal care, exploring individual responses and, ultimately, testing possibilities in a virtual representation of you.
Today, the same technological foundation also powers TwinMe programs for people who want to explore their biology and take an active role in their health.
The evidence, in depth
Open the research.
Follow the progress.
Publications and announcements, with the question studied and the stage of validation.
The virtual twin foundationDigital Twin · 29 May 2024 · Journal article
BioTwin's foundational paper describes the Human Virtual Twin framework and individual biological profiling. It establishes the technology's scientific foundation and the idea of a personal biological reference.
Read the journal articleIndividual identification through metabolic profilesDigital Twin · 21 August 2026 · Journal article
A peer-reviewed study of 1,257 participants, 18,288 samples and 134 analytical batches identifies individuals from their metabolic profiles with 94% user-level accuracy. It addresses biological individuality and repeat measurement.
Read the journal articleMetabolic signatures associated with breast cancermedRxiv · 27 April 2026 · Preprint
A retrospective case-control study includes 2,734 participants: 114 diagnosed breast cancer cases and 2,620 controls. It investigates breast cancer-associated metabolic signatures and identifies prospective evaluation in asymptomatic populations as a next step.
Read the preprintPost-exertional malaise-like fatiguemedRxiv · 10 June 2026 · Preprint
An exploratory cohort study examines metabolic patterns associated with self-reported post-exertional malaise-like fatigue in 1,784 participants, adding to BioTwin's research beyond oncology.
Read the preprintClinical collaboration in Abu DhabiAbu Dhabi Media Office · 31 January 2025 · Institutional announcement
The institutional announcement describes Cleveland Clinic Abu Dhabi's collaboration with BioTwin on a breast cancer pilot. It records Department of Health approval for research purposes at that date. The current medical access pathway is described separately on BioTwin's oncology pages.
Read the institutional announcementPreprints present research before peer review. Dates above refer to the publicly posted version.
BioTwin’s public ecosystem
A larger world
behind the twin.
Medical research, public support and technology expertise all play a part in bringing human virtual twins into the world.
Healthcare & research
Harvard Medical School
Cleveland Clinic Abu Dhabi
Concordia University
Institut de Cardiologie de Québec
Al Jalila Hospital
Department of Health, Abu DhabiGovernment & investment
CED, Canada Economic Development
NRC IRAP
Investissement Québec
Ville de Québec
MBRIF
Mubadala
Hub71
Le CampTechnology & advisors
Microsoft for Startups
Microsoft Entrepreneurship for Positive Impact
Google for Startups
NVIDIA Inception
AWS
IBM
Novo Nordisk
KPMG
Fasken
QuantinoOrganizations presented in BioTwin's public ecosystem.
Roles and institutional sources
Organizations and programs presented in BioTwin's public ecosystem. The documented breast cancer pilot with Cleveland Clinic Abu Dhabi and its research authorization are described in the institutional announcement.
Cleveland Clinic Abu Dhabi
Breast cancer research pilot
A clinical collaboration announced on 31 January 2025.
Department of Health, Abu Dhabi
Research authorization
The 2025 announcement records approval for the pilot for research purposes.
In the news
The story,
in other voices.
Explore television reports, interviews and journalism about BioTwin, its technology and its medical ambition. Coverage is primarily in French.
Radio-Canada
The human virtual twin, explained
Watch the report ↗TVA NouvellesA Quebec biotech and its human virtual twin
Watch the report ↗Planète Techno / ICI ExploraA closer look at BioTwin technology
Watch the segment ↗More media coverage
La Presse